Last reviewed · How we verify

RE and Probiotics in MAFLD/NAFLD

NCT06563921 NA NOT_YET_RECRUITING

This project aims to evaluate the roles of the autonomic nervous system (ANS) and gut microbiota as correlates of clinical improvement in metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD) in response to a therapeutic regimen comprising resistance exercise and probiotic supplementation. The primary objective is to investigate the effects of these non-pharmacological interventions on MAFLD/NAFLD and to identify patient phenotypes based on baseline ANS profiles and gut microbiota composition that predict clinical responses.

Details

Lead sponsorNicolaus Copernicus University
PhaseNA
StatusNOT_YET_RECRUITING
Enrolment180
Start dateFri Apr 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionThu Apr 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions